Immune responses against Aβ1–42 in HLA class II transgenic mice: implications for Aβ1–42 immune-mediated therapies

This publication has 27 references indexed in Scilit:

• Allergic Inflammatory Response to Short Ragweed Allergenic Extract in HLA-DQ Transgenic Mice LackingCD4Gene
  The Journal of Immunology, 2002
• Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid deposition
  Neurobiology of Aging, 2001
• Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
  Proceedings of the National Academy of Sciences, 2001
• Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
  Nature Medicine, 2001
• Type 1 Diabetes-Predisposing MHC Alleles Influence the Selection of Glutamic Acid Decarboxylase (GAD) 65-Specific T Cells in a Transgenic Model
  The Journal of Immunology, 2001
• Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
  Nature Medicine, 2000
• Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis
  Human Immunology, 2000
• An HLA-DRB1∗0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice
  Human Immunology, 1999
• Analysis of HLA-DQ Genotypes and Susceptibility in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1990
• HLA-DQ BETA-CHAIN POLYMORPHISM LINKED TO MYASTHENIA GRAVIS
  The Lancet, 1986